R14 A blood pressure goal 40%, progression to dialysis or renal death), with HR 0.82 95% CI of 0.730.93, p = 0.001 and number needed to treat (NNT) of 29 patients, in addition to lower incidence of secondary cardiovascular outcome (cardiovascular death, AMI, non-fatal stroke, hospitalization for heart failure), HR 0.86 95% CI 0.750.99, p = 0.03 and NNT of 42
Is there a head-to-head trial comparing Zepbound and Wegovy for weight loss
This medication may affect blood sugar levels
By the end of the week, thirteen companies had launched twenty-six brands
Patients in Sandy Springs and Atlanta who suffered severe gastrointestinal injuries, stomach paralysis, or vision loss may have claims not only against drug manufacturers but also against prescribing physicians who failed to follow safe prescribing practices or warn patients about significant risks